TriNetX Readies Its RealWorld Data Platform and Global Network of Healthcare Organizations to Support COVID-19 Clinical Research

TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), has joined the worldwide fight against COVID-19.

TriNetX has fast-tracked updates to its real-world data (RWD) platform to incorporate specific COVID-19 terminology including diagnosis and LOINC terminology and World Health Organization (WHO) and Centers for Disease Control (CDC) specific coding guidelines to support novel coronavirus test results. As a result, COVID-19 clinical data is now flowing in from its global network of healthcare organizations (HCOs). The company is also collaborating with its network of 150 HCOs to connect pharmaceutical companies to sites that are open to receiving COVID-19 clinical trials and observational studies.